1. HOME
2. Research Insight
3. Medtronic plc (Ireland) and Johnson & Johnson (Ethicon) are Leading Players in the Electrosurgery Market

The electrosurgery market is projected to reach USD 9.4 billion by 2029 from USD 6.9 billion in 2024 at a CAGR of 6.4% during the forecast period. Advancements in electrosurgical devices, driven by improvements in energy delivery systems, safety features, and precision tools, are poised to revolutionize the medical field. Enhanced energy delivery ensures precise tissue manipulation while minimizing collateral damage, leading to quicker recovery times and reduced complications. Safety features, including real-time monitoring and automated shutdown protocols, instill confidence among healthcare professionals and patients, driving adoption rates. Integration of precision tools such as miniaturized electrodes and robotics enables unprecedented accuracy in surgeries, reshaping procedures and expanding the scope of minimally invasive techniques. These technological strides are propelling the electrosurgical device market forward, promising greater efficiency and improved patient outcomes across medical specialties.

In this report, the electrosurgery market has been segmented on the basis of product, surgery type, end user, and region.

To know about the assumptions considered for the study download the pdf brochure

Prominent players in electrosurgery market include Medtronic plc (Ireland), Johnson & Johnson (Ethicon) (US), Olympus Corporation (Japan), B. Braun Melsungen (Germany), CONMED Corporation (US), Boston Scientific Corporation (US), Smith and Nephew Plc (UK), Erbe Elektromedizin GmbH (Germany), KLS Martin Group (Germany), BOWA-electronic GmbH & Co. KG (Germany), The Cooper Companies, Inc. (US), Kirwan Surgical Products LLC (US), Zimmer Biomet (US), Utah Medical Products Inc. (US), Encision Inc. (US), Stryker Corporation (US), Meyer-Haake GmbH Medical Innovations (Germany), Surgical Holdings (UK), I. C. Medical, Inc. (US), Aspen Surgical (US), Applied Medical Resources Corporation (US), Apyx Medical (US), EPMD Group (India) and Directa Dental Group (US).

Medtronic, plc.

Medtronic emerges as a key player in the electrosurgery sector, offering a diverse portfolio of products. The company strategically prioritizes research and development endeavors to bolster its market position. Notably, Medtronic has demonstrated significant investment in R&D, with expenditures totaling USD 2,493 million, USD 2,746 million, and USD 2,696 million in 2021, 2022, and 2023, respectively. These substantial financial commitments underscore Medtronic's dedication to fostering innovation and driving advancements in the industry. Consequently, the company has earned recognition for its pioneering contributions, solidifying its esteemed status within the electrosurgery market.

Johnson & Johnson (ethicon).

Johnson & Johnson (Ethicon) holds considerable esteem in the electrosurgery market, benefiting from a robust brand reputation among its customer base. Capitalizing on its robust research and development (R&D) capabilities, the company consistently bolsters its investments in this area to accelerate the pace of innovative product development efforts. Over the fiscal years 2021, 2022, and 2023, Johnson & Johnson allocated substantial funds amounting to USD 14,277 million, USD 14,135 million, and USD 15,085 million, respectively, towards R&D initiatives. These strategic allocations are focused on exploring, experimenting, and enhancing both new and existing products, underscoring the company's steadfast commitment to advancing and excelling in its offerings within the electrosurgery instrument market.

OLYMPUS CORPORATION.

Olympus Corporation is one of the key players in the electrosurgery market, distinguished by its strong leadership ethos and visionary approach. The company is dedicated to continuous improvement, constantly enhancing its product and technology offerings through ongoing upgrades. With a robust global presence and extensive distribution network, Olympus has established itself as a leader on the international stage. Furthermore, Olympus prioritizes substantial investments in research and development, aiming to introduce technologically innovative solutions to its portfolio. This strategic focus not only reinforces the company's position in the electrosurgery market but also reinforces its long-term growth prospects and competitive advantage within the industry.

Related Reports:

Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology, Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]